{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:56:58Z","timestamp":1783612618894,"version":"3.55.0"},"reference-count":74,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001637","name":"Trinity College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J intellect Disabil Res"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The prevalence of epilepsy is higher in people with intellectual disability (ID) and increases with the degree of ID. Although life expectancy for people with ID is increasing, people with ID coexisting with epilepsy have a higher mortality rate, particularly those who had recent seizures. There have been few observational studies of the prevalence and patterns of anti\u2010epileptic prescribing among older people with ID and epilepsy. The aim of this study was to investigate prevalence and patterns of anti\u2010epileptic prescribing in the treatment of epilepsy in a representative population of older people with ID and epilepsy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was an observational cross\u2010sectional study from wave 1 (2009\/2010) of Intellectual Disability Supplement to the Irish Longitudinal Study on Aging, a nationally representative sample of 753 persons with ID aged between 41 and 90\u00a0years. Participants and\/or proxies recorded medicines used on a regular basis and reported doctor's diagnosis of epilepsy; medication data were available for 736 (98%). Prescribing of anti\u2010epileptic drugs (AEDs) for epilepsy in those with a doctor's diagnosis of epilepsy (<jats:italic>N<\/jats:italic>\u00a0=\u00a0205) was the primary exposure of interest for this study. Participant exposure to these AEDs was then categorised into AED monotherapy and polytherapy. Participants\/carers reported seizure frequency, when epilepsy was last reviewed and which practitioner reviewed epilepsy. In addition, medications that may lower the seizure threshold that were listed in the Maudsley prescribing guidelines in psychiatry were examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 736 participants with reported medicines use, 38.9% (<jats:italic>n<\/jats:italic>\u00a0=\u00a0287) were exposed to AEDs, and 30.6% (225) had a doctor's diagnosis of epilepsy. Of those with epilepsy (<jats:italic>n<\/jats:italic>\u00a0=\u00a0225), 90.9% (<jats:italic>n<\/jats:italic>\u00a0=\u00a0205) reported concurrent use of AEDs and epilepsy. Of these 205 participants, 50.3% (<jats:italic>n<\/jats:italic>\u00a0=\u00a0103) were exposed to AED polytherapy, and 63 different polytherapy regimes were reported. The most frequently reported AEDs were valproic acid (<jats:italic>n<\/jats:italic>\u00a0=\u00a0100, 48.7%), carbamazepine (<jats:italic>n<\/jats:italic>\u00a0=\u00a089, 46.3%) and lamotrigine (<jats:italic>n<\/jats:italic>\u00a0=\u00a057, 27.8%). In total, 13.7% had a concurrent psychotropic, which should be avoided in epilepsy, and 32.6% had a psychotropic where caution is required. Antipsychotics with potential epileptogenic potential accounted for 80% of these medications. Of those with AED polytherapy (<jats:italic>n<\/jats:italic>\u00a0=\u00a0103), 29.5% (28) reported being seizure free for the previous 2\u00a0years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Prevalence of epilepsy was high among older people with ID, and half were exposed to two or more AEDs. Despite the use of AED therapy, over half had seizures in the previous 2\u00a0years. As the primary goals of optimal AED treatment are to achieve seizure freedom without unacceptable adverse effects, this was not achievable for many older patients with ID and epilepsy. Our findings indicated that people with ID and epilepsy were often exposed to psychotropic medications that may lower the seizure threshold. Regular review of epilepsy and medicines (including medicines that may interact with AEDs or lower the seizure threshold) by multidisciplinary teams working to agreed standards may improve quality of prescribing. Improved exchange of information and coordination of care between specialists and primary care practitioners in line with expert consensus recommendations could bring substantial benefit.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jir.12461","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T22:29:13Z","timestamp":1515536953000},"page":"245-261","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevalence and patterns of anti\u2010epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities"],"prefix":"10.1111","volume":"62","author":[{"given":"M.","family":"O'Dwyer","sequence":"first","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Dublin Ireland"},{"name":"IDS\u2010TILDA, School of Nursing and Midwifery Trinity College Dublin Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Peklar","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of Ljubljana Ljubljana Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mulryan","sequence":"additional","affiliation":[{"name":"IDS\u2010TILDA, School of Nursing and Midwifery Trinity College Dublin Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"McCallion","sequence":"additional","affiliation":[{"name":"School of Social Work. College of Public Health Temple University Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"McCarron","sequence":"additional","affiliation":[{"name":"Dean of the Faculty of Health Sciences Trinity College Dublin Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Henman","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences Trinity College Dublin Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb04520.x"},{"key":"e_1_2_8_3_1","first-page":"S68","article-title":"Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations","volume":"53","author":"Alldredge B. K.","year":"1998","journal-title":"Neurology"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.09.023"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.537"},{"key":"e_1_2_8_6_1","unstructured":"American Association of Intellectual and Developmental Disabilities. (2014)Definition of intellectual disability[Online]. Available: American Association of Intellectual and Developmental Disabilities [Accessed 21\u20139 2014]."},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","author":"Benjamini Y.","year":"1995","journal-title":"Journal of the Royal Statistical Society: Series B: Methodological"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629020-00001"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(97)80066-0"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0206"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2788.2000.00270.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(98)80005-8"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90940-7"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000165351.10841.fa"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2007.09.001"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818020-00004"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2007.12.019"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90074-4"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13016"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.1990.tb01545.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.1989.tb01459.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3148.2001.00068.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00533.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02238.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00585.x"},{"key":"e_1_2_8_26_1","first-page":"1","article-title":"How people with learning disabilities die","author":"Glover G.","year":"2010","journal-title":"Durham: Improving Health and Lives: Learning Disabilities Observatory"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(97)00153-8"},{"key":"e_1_2_8_28_1","volume-title":"The National Clinical Programme for Epilepsy: Model of Care","author":"Health Services Executive","year":"2016"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jir.12123","article-title":"The relationship between living arrangement and adherence to antiepileptic medications among individuals with developmental disabilities","volume":"59","author":"Hom C.","year":"2014","journal-title":"Journal of Intellectual Disability Research"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(03)00154-7"},{"key":"e_1_2_8_31_1","first-page":"1","article-title":"Pharmacological interventions for epilepsy in people with intellectual disabilities","volume":"9","author":"Jackson C. F.","year":"2015","journal-title":"The Cochrane Library"},{"key":"e_1_2_8_32_1","doi-asserted-by":"crossref","DOI":"10.4324\/9781315820750","volume-title":"Dementia and Aging Adults with Intellectual Disabilities: A Handbook","author":"Janicki M. P.","year":"2014"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.2174\/157015910792246254"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2013.02.004"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12103"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12848"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.2009.01182.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.03.020"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12047"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3281-8"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/1744629506064011"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2011.06.007"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.00502.x"},{"key":"e_1_2_8_44_1","series-title":"Toronto, Canada: Institute for Clinical Evaluative Sciences and Centre for Addiction and Mental Health","first-page":"117","volume-title":"Atlas on the primary care of adults with developmental disabilities in Ontario","author":"Lunsky Y.","year":"2013"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000200993.33730.95"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1352\/1944-7558-119.3.253"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2012.07.029"},{"key":"e_1_2_8_48_1","unstructured":"McCarronM. SwinburneJ. BurkeE. McGlincheyE. MulryanN.&AndrewsV.et al. (2011)Growing older with an intellectual disability in Ireland 2011: first results from the Intellectual Disability Supplement of The Irish Longitudinal Study on Ageing. School of Nursing Trinity College Dublin"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2006.04.002"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1352\/0895-8017(2003)108<293:POEAAH>2.0.CO;2"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001504-200109000-00008"},{"key":"e_1_2_8_52_1","first-page":"1","article-title":"The pharmaceutical care of people with learning disabilities","author":"NHS Scotland","year":"2014","journal-title":"NHS Education for Scotland"},{"key":"e_1_2_8_53_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/bmj.e281","article-title":"Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance","volume":"344","author":"Nunes V. D.","year":"2012","journal-title":"BMJ"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010505"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00483-6"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02529.x"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01579.x"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225020-00004"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2014.918627"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(05)80063-9"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2008.10.009"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.04.004"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.03.016"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.07.020"},{"key":"e_1_2_8_65_1","volume-title":"Good Psychiatric Practice CR203: College Report","author":"Royal College of Psychiatrists","year":"2017"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2010.05.008"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70178-2"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199605010-00004"},{"key":"e_1_2_8_69_1","first-page":"632","volume-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor D.","year":"2015"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.2001.0539"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979584"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.014"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2009.11.002"},{"key":"e_1_2_8_74_1","volume-title":"Neurological Disorders: Public Health Challenges","author":"WHO","year":"2006"},{"key":"e_1_2_8_75_1","unstructured":"World Health Organization Anatomical Therapeutic Classification System. (2015) Available at:http:\/\/www.whocc.no\/atc\/structure_and_principles\/(accessed 25 May 2015)"}],"container-title":["Journal of Intellectual Disability Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjir.12461","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jir.12461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T11:17:11Z","timestamp":1719746231000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jir.12461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1111\/jir.12461"],"URL":"https:\/\/doi.org\/10.1111\/jir.12461","archive":["Portico"],"relation":{},"ISSN":["0964-2633","1365-2788"],"issn-type":[{"value":"0964-2633","type":"print"},{"value":"1365-2788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]},"assertion":[{"value":"2016-10-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}